Condition: Heart Failure With Reduced Ejection Fraction · Ischemic Cardiomyopathy · Sponsor: Samsung Medical Center
Randomized trial to compare clinical outcomes between revascularization versus medical treatment alone in patients with ischemic cardiomyopathy and left ventricular dysfunction.
This description comes directly from the study's public registry record.
Young Bin Song, MD, PhD · 82-2-3410-6653 · youngbien.song@samsung.com
Joo Myung Lee, MD, MPH, PhD · 82-2-3410-3419 · drone80@hanmail.net
Always discuss trial participation with your own doctor first.
| Samsune Medical Center | Seoul, South Korea | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05828719